Naftchi N E, Maker H, Lapin E, Sleis J, Lajtha A, Leeman S
Institute of Rehabilitation Medicine, NYU Medical Center, New York.
Neurochem Res. 1988 Apr;13(4):305-9. doi: 10.1007/BF00972478.
Ten minutes after a single injection of 0.8 mg/kg nicotine SC (free base) the level of substance P-like immunoreactivity (SPLI) was reduced by 61-73% in rat caudate-putamen, nucleus accumbens, and olfactory tubercle, with smaller and not significant reductions in the frontal cortex, substantia nigra, and ventral tegmental area. The nicotinic receptor antagonist mecamylamine (1.0 mg/kg IP) prevented the reductions in SPLI. The rapidity and the degree of the changes in SPLI after nicotine exceed those previously reported for other agents and implicate substance P neurotransmission as a major component of nicotinic action.